Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Inflammatory Bowel Diseases

Free Subscription Articles published in Dig Dis Retrieve available abstracts of 35 articles: HTML format

Single Articles

September 2023
1. YANG MM, Usiskin K, Ahmad HA, Ather S, et al
   Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials.
   Dig Dis. 2023 Sep 27. doi: 10.1159/000533395.
   PubMed     Abstract available
   
   
   
2. BOLDOVJAKOVA D, El-Abbassy I, Alarcon I, El-Saify M, et al
   Management of the Rectal Stump after Subtotal Colectomy Operations for Inflammatory Bowel Disease in the Era of Immunologic Therapy: A Two-Centre Cohort Study.
   Dig Dis. 2023 Sep 8:1-7. doi: 10.1159/000533267.
   PubMed     Abstract available
   
   
   August 2023
3. BASTIDA PAZ G, Merino Ochoa O, Aguas Peris M, Barreiro-de Acosta M, et al
   The Risk of Developing Disabling Crohn's Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making.
   Dig Dis. 2023 Aug 23:1-11. doi: 10.1159/000531789.
   PubMed     Abstract available
   
   
   June 2023
4. NERI B, Russo C, Mossa M, Martire FG, et al
   High Frequency of Deep Infiltrating Endometriosis in Patients with Inflammatory Bowel Disease: A Nested Case-Control Study.
   Dig Dis. 2023 Jun 30:1. doi: 10.1159/000530896.
   PubMed     Abstract available
   
   
   
5. SURDEA-BLAGA T, Ismaiel A, Jaaouani A, Leucuta DC, et al
   Adiponectin Levels in Inflammatory Bowel Disease - A Systematic Review and Meta-analysis.
   Dig Dis. 2023 Jun 29. doi: 10.1159/000531614.
   PubMed     Abstract available
   
   
   
6. SHI H, Zeng H, Wang M, Jiang J, et al
   Effectiveness of water-assisted colonoscopy without sedation in patients with ulcerative colitis.
   Dig Dis. 2023 Jun 27. doi: 10.1159/000531652.
   PubMed     Abstract available
   
   
   March 2023
7. SALEH A, Parsa S, Garza M, Quigley EMM, et al
   The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis.
   Dig Dis. 2023 Mar 1. doi: 10.1159/000529591.
   PubMed     Abstract available
   
   
   January 2023
8. BARAJAS ORDONEZ F, Melekh B, Rodriguez-Feria P, Melekh O, et al
   Body composition predictors of complicated Crohn's disease.
   Dig Dis. 2023 Jan 31. doi: 10.1159/000529426.
   PubMed     Abstract available
   
   
   
9. RAMOS L, Reygosa C, Carrillo-Palau M, Alonso-Abreu I, et al
   EFFICACY, EFFICIENCY, AND ACCEPTABILITY OF TELEMEDICINE FOR INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOW-UP CARE DURING THE COVID-19 PANDEMIC.
   Dig Dis. 2023 Jan 30. doi: 10.1159/000529106.
   PubMed     Abstract available
   
   
   
10. HILMI IN, Nik Muhammad Affendi NA, Shahrani S, Thalha AM, et al
    High accuracy of a simplified, practical algorithm in differentiating Crohn's Disease from Intestinal Tuberculosis.
    Dig Dis. 2023 Jan 26. doi: 10.1159/000529238.
    PubMed     Abstract available
    
    
    
11. DUBINSKY MC, Armuzzi A, Gecse KB, Ullman T, et al
    Improvements in disease activity partially mediate the effect of tofacitinib treatment on generic and disease-specific health-related quality of life in patients with ulcerative colitis: data from the OCTAVE program.
    Dig Dis. 2023 Jan 5. doi: 10.1159/000528788.
    PubMed     Abstract available
    
    
    
12. HELWIG U, Krause TH, Maaser C, Buning J, et al
    Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational Trial.
    Dig Dis. 2023;41:239-249.
    PubMed     Abstract available
    
    
    
13. PELEG N, Yanai H, Gingold-Belfer R, Dotan I, et al
    Video Capsule Endoscopy after Bariatric Surgery: A Tertiary Referral Center Experience.
    Dig Dis. 2023;41:233-238.
    PubMed     Abstract available
    
    
    
14. KRAL J, Nakov R, Lanska V, Barberio B, et al
    Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey.
    Dig Dis. 2023;41:387-395.
    PubMed     Abstract available
    
    
    December 2022
15. VAN DEEN WK, Khalil C, Bonthala NN, Gale R, et al
    Inflammatory Bowel Disease Patients' Preferences for Subcutaneous Versus Intravenous Therapies: A Mixed Methods Study.
    Dig Dis. 2022 Dec 7. doi: 10.1159/000528586.
    PubMed     Abstract available
    
    
    
16. YOU L, Bai C, Wang S, Yu X, et al
    The prevalence and factors that impact frailty in Inflammatory Bowel disease patients hospitalized in a tertiary hospital in China.
    Dig Dis. 2022 Dec 1. doi: 10.1159/000528459.
    PubMed     Abstract available
    
    
    January 2022
17. FADEN H
    The Role of Faecalibacterium, Roseburia and Butyrate in Inflammatory Bowel Disease.
    Dig Dis. 2022 Jan 27. pii: 000522247. doi: 10.1159/000522247.
    PubMed     Abstract available
    
    
    
18. MIYAZAKI R, Sakurai T, Iwashita Y, Shimada M, et al
    Characteristics and Endoscopic Classification of Ulcerative Lesions Affecting the Ileocecal Valve.
    Dig Dis. 2022;40:239-245.
    PubMed     Abstract available
    
    
    
19. CHEN F, Dai Z, Huang C, Chen H, et al
    Gastrointestinal Disease and COVID-19: A Review of Current Evidence.
    Dig Dis. 2022;40:506-514.
    PubMed     Abstract available
    
    
    December 2021
20. FERRARESE D, Spagnolo G, Vecchione M, Scaldaferri F, et al
    Signs of dissociation and symptoms of post-traumatic stress disorder in inflammatory bowel disease. A case-control study.
    Dig Dis. 2021 Dec 17. pii: 000521424. doi: 10.1159/000521424.
    PubMed     Abstract available
    
    
    
21. CLASSEN JM, Muzalyova A, Nagl S, Fleischmann C, et al
    Antibody response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease - results of a single-center cohort study in a tertiary hospital in Germany.
    Dig Dis. 2021 Dec 10. pii: 000521343. doi: 10.1159/000521343.
    PubMed     Abstract available
    
    
    
22. LONG MD, Cohen RD, Smith TW, DiBonaventura M, et al
    Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis.
    Dig Dis. 2021 Dec 8. pii: 000521299. doi: 10.1159/000521299.
    PubMed     Abstract available
    
    
    February 2021
23. SORRENTINO D, Nguyen VQ, Love K
    Fecal lactoferrin predicts primary non-response to biologic agents in inflammatory bowel disease.
    Dig Dis. 2021 Feb 25. pii: 000515432. doi: 10.1159/000515432.
    PubMed     Abstract available
    
    
    
24. LEAL T, Goncalves M, Antunes P, Costa D, et al
    Sleep disturbance in Inflammatory Bowel Disease is associated with disease activity and adverse outcome.
    Dig Dis. 2021 Feb 15. pii: 000515218. doi: 10.1159/000515218.
    PubMed     Abstract available
    
    
    January 2021
25. STREMMEL W, Vural H, Evliyaoglu O, Weiskirchen R, et al
    Delayed Release Phosphatidylcholine is Effective for Treatment of Ulcerative Colitis: A Meta-Analysis.
    Dig Dis. 2021 Jan 13. pii: 000514355. doi: 10.1159/000514355.
    PubMed     Abstract available
    
    
    
26. MATEOS B, Saez-Gonzalez E, Moret I, Hervas D, et al
    Plasma Oncostatin M, TNF-alpha, IL-7, and IL-13 Network Predicts Crohn's Disease Response to Infliximab, as Assessed by Calprotectin Log Drop.
    Dig Dis. 2021;39:1-9.
    PubMed     Abstract available
    
    
    
27. HUNT RH, East JE, Lanas A, Malfertheiner P, et al
    COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist.
    Dig Dis. 2021;39:119-139.
    PubMed     Abstract available
    
    
    
28. GRASS F, Zhu E, Brunel C, Hubner M, et al
    Crohn's versus Cancer: Comparison of Functional and Surgical Outcomes after Right-Sided Resections.
    Dig Dis. 2021;39:106-112.
    PubMed     Abstract available
    
    
    
29. RUEDA GARCIA JL, Suarez-Ferrer C, Poza Cordon J, Martin-Arranz E, et al
    Doppler Activity and Ultrasonographic Detection of Intra-Abdominal Fistulas Are Predictors of Surgery in Crohn's Disease.
    Dig Dis. 2021;39:204-210.
    PubMed     Abstract available
    
    
    
30. DE SOUSA MAGALHAES R, Xavier S, Curdia Goncalves T, Dias de Castro F, et al
    Does Perianal Disease Influence the Efficacy of Combination Therapy in Crohn's Disease?
    Dig Dis. 2021;39:417-428.
    PubMed     Abstract available
    
    
    
31. KOSLOWSKY B, Mazuz B, Ben-Ya'acov A, Neumark A, et al
    Gastroenterologists' Attitude Regarding Medical Cannabis for Inflammatory Bowel Diseases in Israel.
    Dig Dis. 2021;39:502-507.
    PubMed     Abstract available
    
    
    November 2020
32. YU T, Meng F, Xie M, Liu H, et al
    LncRNA PMS2L2 downregulates miR-24 through methylation to suppress cell apoptosis in ulcerative colitis.
    Dig Dis. 2020 Nov 25. pii: 000513330. doi: 10.1159/000513330.
    PubMed     Abstract available
    
    
    January 2020
33. REISCHL S, Troger J, Jesinghaus M, Kasajima A, et al
    Annexin A1 Expression Capacity as a Determinant for Disease Severity in Crohn's Disease.
    Dig Dis. 2020;38:398-407.
    PubMed     Abstract available
    
    
    
34. KANI HT, Sakalli Kani A, Dural U, Basgoze E, et al
    The Effect of Dream Anxiety on Sleep Quality in Inflammatory Bowel Diseases.
    Dig Dis. 2020;38:380-389.
    PubMed     Abstract available
    
    
    
35. LU R, Kassim T, Dave D, Klair JS, et al
    Diagnostic Yield of Colonoscopy in Young Adults with Lower Gastrointestinal Symptoms in a Multicenter Midwest Cohort.
    Dig Dis. 2020;38:484-489.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.